16-172976-G-C

Variant summary

Our verdict is Uncertain significance. The variant received 2 ACMG points: 3P and 1B. PM1PP3BP6

The NM_000517.6(HBA2):​c.64G>C​(p.Ala22Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0 ( 0 hom., cov: 2)
Exomes 𝑓: 0.000022 ( 1 hom. )
Failed GnomAD Quality Control

Consequence

HBA2
NM_000517.6 missense

Scores

3
8
4

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 0.550

Publications

1 publications found
Variant links:
Genes affected
HBA2 (HGNC:4824): (hemoglobin subunit alpha 2) The human alpha globin gene cluster located on chromosome 16 spans about 30 kb and includes seven loci: 5'- zeta - pseudozeta - mu - pseudoalpha-1 - alpha-2 - alpha-1 - theta - 3'. The alpha-2 (HBA2) and alpha-1 (HBA1) coding sequences are identical. These genes differ slightly over the 5' untranslated regions and the introns, but they differ significantly over the 3' untranslated regions. Two alpha chains plus two beta chains constitute HbA, which in normal adult life comprises about 97% of the total hemoglobin; alpha chains combine with delta chains to constitute HbA-2, which with HbF (fetal hemoglobin) makes up the remaining 3% of adult hemoglobin. Alpha thalassemias result from deletions of each of the alpha genes as well as deletions of both HBA2 and HBA1; some nondeletion alpha thalassemias have also been reported. [provided by RefSeq, Jul 2008]
HBA2 Gene-Disease associations (from GenCC):
  • alpha thalassemia spectrum
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen
  • erythrocytosis, familial, 7
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • hemoglobin M disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Hb Bart's hydrops fetalis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • hemoglobin H disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Heinz body anemia
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
  • methemoglobinemia, alpha type
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 2 ACMG points.

PM1
In a hotspot region, there are 5 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 6 benign, 14 uncertain in NM_000517.6
PP3
MetaRNN computational evidence supports a deleterious effect, 0.773
BP6
Variant 16-172976-G-C is Benign according to our data. Variant chr16-172976-G-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 801178.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000517.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HBA2
NM_000517.6
MANE Select
c.64G>Cp.Ala22Pro
missense
Exon 1 of 3NP_000508.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HBA2
ENST00000251595.11
TSL:1 MANE Select
c.64G>Cp.Ala22Pro
missense
Exon 1 of 3ENSP00000251595.6
HBA2
ENST00000484216.1
TSL:1
c.31G>Cp.Ala11Pro
missense
Exon 1 of 2ENSP00000495899.1
HBA2
ENST00000482565.1
TSL:1
n.83G>C
non_coding_transcript_exon
Exon 1 of 2

Frequencies

GnomAD3 genomes
AF:
0.00
AC:
0
AN:
4754
Hom.:
0
Cov.:
2
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000188
AC:
1
AN:
53330
AF XY:
0.0000372
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000219
AC:
9
AN:
411840
Hom.:
1
Cov.:
0
AF XY:
0.0000323
AC XY:
7
AN XY:
216496
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
10010
American (AMR)
AF:
0.00
AC:
0
AN:
17684
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
12684
East Asian (EAS)
AF:
0.00
AC:
0
AN:
28100
South Asian (SAS)
AF:
0.000158
AC:
7
AN:
44180
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
26802
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
1778
European-Non Finnish (NFE)
AF:
0.00000405
AC:
1
AN:
247048
Other (OTH)
AF:
0.0000425
AC:
1
AN:
23554
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AC0;AS_VQSR
AF:
0.00
AC:
0
AN:
4724
Hom.:
0
Cov.:
2
AF XY:
0.00
AC XY:
0
AN XY:
2328
African (AFR)
AF:
0.00
AC:
0
AN:
674
American (AMR)
AF:
0.00
AC:
0
AN:
788
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
82
East Asian (EAS)
AF:
0.00
AC:
0
AN:
548
South Asian (SAS)
AF:
0.00
AC:
0
AN:
514
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
140
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
28
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1854
Other (OTH)
AF:
0.00
AC:
0
AN:
84

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
Dec 09, 2024
Quest Diagnostics Nichols Institute San Juan Capistrano
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The HB2 c.64G>C (p.Ala22Pro), also known as Hb Fontainebleau, variant is reported as having normal stability (see HbVar, http://globin.bx.psu.edu/cgi-bin/hbvar/counter, PMID: 2599878 (2009)). This variant has been observed in a screening study of alpha thalassemia carriers (PMID: 29627922 (2018)). It has also been detected in an individual with suspected hemoglobinopathy (PMID: 38708170 (2024)). The variant has been reported in homozygous and compound heterozygous individuals with microcytosis (PMID: 22461654 (2012), 24826794 (2014), 26036869 (2015), and 30728682 (2019)) as well as in individuals with normal red cell indices (PMID: 19657841 (2009)). Based on the available information, we are unable to determine the clinical significance of this variant.

Mar 23, 2022
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.25
BayesDel_addAF
Uncertain
0.11
D
BayesDel_noAF
Pathogenic
0.19
CADD
Benign
17
DANN
Uncertain
0.98
Eigen
Benign
-0.70
Eigen_PC
Benign
-0.75
FATHMM_MKL
Benign
0.11
N
M_CAP
Pathogenic
0.62
D
MetaRNN
Pathogenic
0.77
D
MetaSVM
Uncertain
-0.098
T
PhyloP100
0.55
PrimateAI
Uncertain
0.65
T
PROVEAN
Uncertain
-2.5
N
REVEL
Uncertain
0.57
Sift
Uncertain
0.014
D
Sift4G
Uncertain
0.056
T
Vest4
0.22
MutPred
0.83
Gain of methylation at K17 (P = 0.0559)
MVP
1.0
MPC
1.7
ClinPred
0.085
T
GERP RS
3.0
PromoterAI
-0.017
Neutral
gMVP
0.95
Mutation Taster
=76/24
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs281864817; hg19: chr16-222975; API